MTL Cannabis Corp C.MTLC

Alternate Symbol(s): MTLNF

Cannabis

MTL Cannabis Corp. is focused on crafting cannabis products, including lines of dried flower, pre-rolls and hash marketed. The Company, through its subsidiaries, is engaged in the cultivation and production of cannabis products for recreational and medical purposes in Canada. It also operates clinics that work directly with primary care teams to provide specialized cannabinoid therapy services to patients suffering from medical conditions. Its wholly owned subsidiaries include Montreal Medical Cannabis Inc. (Montreal Cannabis), Abba Medix Corp. (Abba), Canada House Clinics Inc. (CHC), and IsoCanMed Inc. (ICM). Montreal Medical is a licensed producer operating from a 57,000 sq ft licensed indoor growing facility in Pointe Claire, Quebec. Abba is a licensed producer in Pickering, Ontario that operates a medical cannabis marketplace. CHC is operating clinics across Canada. ICM is a licensed producer in Louiseville, Quebec growing indoor cannabis in its 64,000 sq. ft. production facility.

CSE:MTLC - Post by User

MTL Cannabis Corp

Bullboard Posts

Post by SenorLegumeon Oct 29, 2018 9:00am

54 Views

Post# 28886154

Ed Begley Jr. Fox Business News

In March 2018 Canada House reported interest from the TV show, Innovations. I recently asked if this is still happening.

Yes it is being worked on between corporate office and the show on scheduling. Of course anything is possible for TV shows but I thought it important to clear up why it has not happened yet. Good times ahead!

https://innovationstelevision.com/

TORONTO, March 09, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE:CHV) (“Canada House” or the “Company”) is pleased to announce that it has been selected to be featured by the Innovations TV Series in the second quarter of this year on Fox Business.
Innovations with Ed Begley Jr. is particularly interested in how Canada House is treating complex health issues through ongoing education, support, and data-driven cannabinoid treatment therapy.

Operating in concert, the three Canada House subsidiaries generate world-leading data and drive shareholder value through the delivery of cannabinoid therapy services (Marijuana For Trauma Inc.), evidence-based treatment plans (Knalysis Technology) and high quality medical cannabis (Abba Medix).

In this episode, Innovations will explore how Canada House improves Canadians’ lives through client-focused, evidence-based cannabis patient solutions and products. Focusing on three distinct sectors, the show will educate viewers on how Canada House and its subsidiaries treat complex health issues through ongoing education and data-driven cannabinoid therapy treatment, leverage data generated by its own operations to improve patient outcomes, and produce efficacious cannabis genetics and products to help its patient base achieve optimum health outcomes.

Read more at https://www.stockhouse.com/news/press-releases/2018/03/09/innovations-with-ed-begley-jr-to-feature-canada-houses-evidence-based-cannabis#BUoxx1jGFUu7ASOc.99